Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25; 391(4):320-333.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Bispecific
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Consolidation Chemotherapy
Disease-Free Survival
Female
Humans
Induction Chemotherapy
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm, Residual
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Remission Induction
Survival Analysis
authors with profiles
Daniel Arber